Fresenius Kabi Compounding, LLC is recalling 14,593 bags of various sterile injectable medications including ketamine, acyclovir, thiamine, and vancomycin. The recall was initiated because the products lack assurance of sterility, which means they may not be completely free of microorganisms. These medications are administered intravenously in clinical or hospital settings and were distributed nationwide across the United States.
Administering a drug intended to be sterile that is contaminated with microorganisms could lead to serious, life-threatening infections, particularly in vulnerable patients. No specific injuries or infections have been reported to date, but the lack of sterility assurance poses a significant safety risk during intravenous use.
Recall #: D-0334-2026; Quantity: 1410 bags
Recall #: D-0333-2026; Quantity: 1057 bags
Recall #: D-0335-2026; Quantity: 10,548 bags
Recall #: D-0336-2026; Quantity: 1578 bags
Recall #: D-0337-2026
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.